Dr. Francisco Lozano is currently a Senior Consultant at the Immunology Department of Hospital Clínic of Barcelona, a Full Professor of Immunology at the School of Medicine from the University of Barcelona (UB) and director of the research group "Immunoreceptors of the Innate and Adaptive system" at Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in Barcelona. He graduated in Medicine (Extraordinary Degree Award, 1982) at UB and specialized in Immunology via M.I.R. at Hospital Clínic of Barcelona (1984-1988). After obtaining his Ph.D. in Medicine (UB, 1990), he completed a 3-year post-doctoral stay (1991-1993) at the Laboratory of Molecular Biology-MRC (Cambridge, UK) under the supervision of Prof. César Milstein. There, he worked on transgenic models of somatic hypermutation and transcriptional control of immunoglobulin genes, and his contributions made in this field deserved publication in prestigious scientific journals (Nature, EMBO). Afterward, he was enrolled as a staff member of the Immunology Department of Hospital Clínic of Barcelona (1994), where he set up his research group initially focused on the physiology of lymphocyte cell surface co-receptors involved in lymphocyte activation and differentiation. He has also served as a reviewer member of national (Agencia Nacional de Evaluación y Prospectiva) and international (Sanquin Foundation, The Wellcome Trust Foundation, The Wellcome Trust/DBT India Alliance) evaluation and funding agencies.
Dr. Francisco Lozano is currently a Senior Consultant at the Immunology Department of Hospital Clínic of Barcelona, a Full Professor of Immunology at the School of Medicine from the University of Barcelona (UB) and director of the research group "Immunoreceptors of the Innate and Adaptive system" at Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in Barcelona. He graduated in Medicine (Extraordinary Degree Award, 1982) at UB and specialized in Immunology via M.I.R. at Hospital Clínic of Barcelona (1984-1988). After obtaining his Ph.D. in Medicine (UB, 1990), he completed a 3-year post-doctoral stay (1991-1993) at the Laboratory of Molecular Biology-MRC (Cambridge, UK) under the supervision of Prof. César Milstein. There, he worked on transgenic models of somatic hypermutation and transcriptional control of immunoglobulin genes, and his contributions made in this field deserved publication in prestigious scientific journals (Nature, EMBO). Afterward, he was enrolled as a staff member of the Immunology Department of Hospital Clínic of Barcelona (1994), where he set up his research group initially focused on the physiology of lymphocyte cell surface co-receptors involved in lymphocyte activation and differentiation. He has also served as a reviewer member of national (Agencia Nacional de Evaluación y Prospectiva) and international (Sanquin Foundation, The Wellcome Trust Foundation, The Wellcome Trust/DBT India Alliance) evaluation and funding agencies.